Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 Dec 7;3(3):361–367. doi: 10.1016/j.gastha.2023.11.020

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2024 The Authors

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

PMC Copyright notice

(A) Serial pancreatic volume (median, cm³) in relation to time of lipase elevation among patients with normal CT at presentation of type 3 AIP. (B) Serial pancreatic volume (median, cm³) in relation to time of lipase elevation among patients with pancreatitis on CT at presentation of type 3 AIP. (C) Percentage of patients with ≥ 20% pancreatic volume loss at 1 year with normal CT and pancreatitis on CT at presentation of type 3 AIP in comparison to controls. (D) Serial pancreatic volume (median, cm³) in relation to before and 1 year after ICI exposure among patients with and without pain at presentation of type 3 AIP. (E) Serial pancreatic volume (median, cm³) in relation to before and 1 year after ICI exposure among patients with and without steroid exposure for type 3 AIP. (F) Percentage of patients with ≥ 20% pancreatic volume loss at 1 year with or without steroid exposure at presentation of type 3 AIP.